INFU vs TCMD
INFU: InfuSystem is a specialized provider of durable medical equipment and managed healthcare services that enables the seamless transition of oncology and other infusion therapies from clinical settings to the home. TCMD: Tactile Medical develops at-home therapeutic medical devices that improve quality of life and reduce healthcare costs for patients with chronic vascular and respiratory conditions.
Side-by-side fundamentals
| Metric | INFU | TCMD | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $8.90 | $27.62 | |
| Market cap as of 2026-07-23 | $185M | $622M | |
| P/E as of 2026-07-23 | 23.34 | 30.65 | INFU lower |
| PEG as of 2026-07-23 | 0.16 | 0.95 | INFU lower |
| Net margin as of 2026-07-23 | +5.6% | +5.9% | TCMD higher |
| Gross margin as of 2026-07-23 | +56.8% | +51.3% | INFU higher |
| Operating margin as of 2026-07-23 | +9.1% | +9.4% | TCMD higher |
| ROE as of 2026-07-23 | +14.0% | +9.7% | INFU higher |
| ROA as of 2026-07-23 | +7.9% | +7.5% | INFU higher |
| Debt / equity as of 2026-07-23 | 0.33 | 0.00 | TCMD lower |
| Revenue growth (YoY) as of 2026-07-23 | +3.5% | +17.2% | TCMD higher |
| Revenue CAGR (3y) SEC XBRL | +9.3% | +10.1% | TCMD higher |
| Beta as of 2026-07-23 | 1.49 | 0.82 | |
| 1-year return as of 2026-07-22 close | +66.1% | +176.5% | TCMD higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.